Which has better valuation & earnings, IOF or ESNT?

Iofina has higher earnings, but lower revenue than Essentra. Iofina is trading at a lower price-to-earnings ratio than Essentra, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Iofina £66.52M 1.61 £4.28M £4.00 13.96 Essentra £302M 0.79 £3.50M £0.70 119.71

Is IOF or ESNT more profitable?

Iofina has a net margin of 11.84% compared to Essentra's net margin of 0.70%. Iofina's return on equity of 14.89% beat Essentra's return on equity. Company Net Margins Return on Equity Return on Assets Iofina 11.84% 14.89% 5.18% Essentra 0.70% 0.79% 1.74%

Does the media prefer IOF or ESNT?

In the previous week, Iofina and Iofina both had 1 articles in the media. Essentra's average media sentiment score of 0.75 beat Iofina's score of 0.00 indicating that Essentra is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Iofina 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Essentra 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings and valuation, ZTF or IOF?

Zotefoams has higher revenue and earnings than Iofina. Zotefoams is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zotefoams £158.49M 1.34 £9.80M £44.87 9.61 Iofina £66.52M 1.61 £4.28M £4.00 13.96

Is ZTF or IOF more profitable?

Zotefoams has a net margin of 14.28% compared to Iofina's net margin of 11.84%. Zotefoams' return on equity of 18.25% beat Iofina's return on equity. Company Net Margins Return on Equity Return on Assets Zotefoams 14.28% 18.25% 5.48% Iofina 11.84% 14.89% 5.18%

Which has better earnings & valuation, TET or IOF?

Treatt has higher revenue and earnings than Iofina. Iofina is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Treatt £128.29M 1.40 £11.22M £7.22 42.24 Iofina £66.52M 1.61 £4.28M £4.00 13.96

Is TET or IOF more profitable?

Iofina has a net margin of 11.84% compared to Treatt's net margin of 3.40%. Iofina's return on equity of 14.89% beat Treatt's return on equity. Company Net Margins Return on Equity Return on Assets Treatt 3.40% 3.22% 6.72% Iofina 11.84% 14.89% 5.18%

Which has preferable earnings and valuation, SYNT or IOF?

Iofina has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Synthomer £1.74B 0.08 -£82.04M -£96.00 N/A Iofina £66.52M 1.61 £4.28M £4.00 13.96

Is SYNT or IOF more profitable?

Iofina has a net margin of 11.84% compared to Synthomer's net margin of -9.03%. Iofina's return on equity of 14.89% beat Synthomer's return on equity. Company Net Margins Return on Equity Return on Assets Synthomer -9.03% -16.66% -0.28% Iofina 11.84% 14.89% 5.18%

Do analysts recommend IOF or HDD?

Iofina currently has a consensus price target of GBX 60, suggesting a potential upside of 7.45%. Given Iofina's stronger consensus rating and higher probable upside, equities analysts plainly believe Iofina is more favorable than Hardide. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Iofina 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Hardide 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher valuation & earnings, IOF or HDD?

Iofina has higher revenue and earnings than Hardide. Iofina is trading at a lower price-to-earnings ratio than Hardide, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Iofina £66.52M 1.61 £4.28M £4.00 13.96 Hardide £8.02M 7.21 -£1.89M £1.80 40.78

Is IOF or HDD more profitable?

Hardide has a net margin of 15.60% compared to Iofina's net margin of 11.84%. Hardide's return on equity of 32.49% beat Iofina's return on equity. Company Net Margins Return on Equity Return on Assets Iofina 11.84% 14.89% 5.18% Hardide 15.60% 32.49% -9.80%

Iofina (IOF) Competitors

GBX 55.84 -1.16 (-2.04%)

As of 11:48 AM Eastern

Compare

IOF vs. ESNT, ZTF, TET, SYNT, and HDD

Should you buy Iofina stock or one of its competitors? MarketBeat compares Iofina with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Iofina include Essentra (ESNT), Zotefoams (ZTF), Treatt (TET), Synthomer (SYNT), and Hardide (HDD). These companies are all part of the "specialty chemicals" industry.

How does Iofina compare to Essentra?

Iofina (LON:IOF) and Essentra (LON:ESNT) are both small-cap basic materials companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, risk, profitability, media sentiment, analyst recommendations, institutional ownership and valuation.

Iofina has higher earnings, but lower revenue than Essentra. Iofina is trading at a lower price-to-earnings ratio than Essentra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Iofina	£66.52M	1.61	£4.28M	£4.00	13.96
Essentra	£302M	0.79	£3.50M	£0.70	119.71

Iofina has a net margin of 11.84% compared to Essentra's net margin of 0.70%. Iofina's return on equity of 14.89% beat Essentra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Iofina	11.84%	14.89%	5.18%
Essentra	0.70%	0.79%	1.74%

Iofina currently has a consensus target price of GBX 60, indicating a potential upside of 7.45%. Essentra has a consensus target price of GBX 150, indicating a potential upside of 79.00%. Given Essentra's higher probable upside, analysts plainly believe Essentra is more favorable than Iofina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Essentra	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80

1.5% of Iofina shares are owned by institutional investors. Comparatively, 69.5% of Essentra shares are owned by institutional investors. 13.4% of Iofina shares are owned by company insiders. Comparatively, 0.5% of Essentra shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Iofina and Iofina both had 1 articles in the media. Essentra's average media sentiment score of 0.75 beat Iofina's score of 0.00 indicating that Essentra is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Iofina	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Essentra	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Iofina has a beta of 0.86, meaning that its stock price is 14% less volatile than the broader market. Comparatively, Essentra has a beta of 0.829, meaning that its stock price is 17% less volatile than the broader market.

Summary

Iofina beats Essentra on 9 of the 15 factors compared between the two stocks.

How does Iofina compare to Zotefoams?

Zotefoams (LON:ZTF) and Iofina (LON:IOF) are both small-cap basic materials companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk, media sentiment and dividends.

Zotefoams has a beta of 1.239, indicating that its share price is 24% more volatile than the broader market. Comparatively, Iofina has a beta of 0.86, indicating that its share price is 14% less volatile than the broader market.

Zotefoams has higher revenue and earnings than Iofina. Zotefoams is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zotefoams	£158.49M	1.34	£9.80M	£44.87	9.61
Iofina	£66.52M	1.61	£4.28M	£4.00	13.96

Zotefoams has a net margin of 14.28% compared to Iofina's net margin of 11.84%. Zotefoams' return on equity of 18.25% beat Iofina's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zotefoams	14.28%	18.25%	5.48%
Iofina	11.84%	14.89%	5.18%

In the previous week, Iofina had 1 more articles in the media than Zotefoams. MarketBeat recorded 1 mentions for Iofina and 0 mentions for Zotefoams. Zotefoams' average media sentiment score of 0.00 equaled Iofina'saverage media sentiment score.

Company	Overall Sentiment
Zotefoams	Neutral
Iofina	Neutral

29.4% of Zotefoams shares are owned by institutional investors. Comparatively, 1.5% of Iofina shares are owned by institutional investors. 4.5% of Zotefoams shares are owned by insiders. Comparatively, 13.4% of Iofina shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Zotefoams presently has a consensus target price of GBX 605, indicating a potential upside of 40.37%. Iofina has a consensus target price of GBX 60, indicating a potential upside of 7.45%. Given Zotefoams' higher possible upside, equities analysts clearly believe Zotefoams is more favorable than Iofina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Zotefoams beats Iofina on 10 of the 14 factors compared between the two stocks.

How does Iofina compare to Treatt?

Treatt (LON:TET) and Iofina (LON:IOF) are both small-cap basic materials companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, earnings and institutional ownership.

17.5% of Treatt shares are owned by institutional investors. Comparatively, 1.5% of Iofina shares are owned by institutional investors. 4.1% of Treatt shares are owned by insiders. Comparatively, 13.4% of Iofina shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Treatt has a beta of 0.907, suggesting that its share price is 9% less volatile than the broader market. Comparatively, Iofina has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market.

Iofina has a net margin of 11.84% compared to Treatt's net margin of 3.40%. Iofina's return on equity of 14.89% beat Treatt's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Treatt	3.40%	3.22%	6.72%
Iofina	11.84%	14.89%	5.18%

Treatt currently has a consensus price target of GBX 248.33, indicating a potential downside of 18.58%. Iofina has a consensus price target of GBX 60, indicating a potential upside of 7.45%. Given Iofina's stronger consensus rating and higher possible upside, analysts clearly believe Iofina is more favorable than Treatt.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Treatt	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, Iofina had 1 more articles in the media than Treatt. MarketBeat recorded 1 mentions for Iofina and 0 mentions for Treatt. Treatt's average media sentiment score of 0.00 equaled Iofina'saverage media sentiment score.

Company	Overall Sentiment
Treatt	Neutral
Iofina	Neutral

Treatt has higher revenue and earnings than Iofina. Iofina is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Treatt	£128.29M	1.40	£11.22M	£7.22	42.24
Iofina	£66.52M	1.61	£4.28M	£4.00	13.96

Summary

Treatt and Iofina tied by winning 7 of the 14 factors compared between the two stocks.

How does Iofina compare to Synthomer?

Synthomer (LON:SYNT) and Iofina (LON:IOF) are both small-cap basic materials companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, media sentiment, profitability, dividends, analyst recommendations, institutional ownership, earnings and risk.

Iofina has a net margin of 11.84% compared to Synthomer's net margin of -9.03%. Iofina's return on equity of 14.89% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Synthomer	-9.03%	-16.66%	-0.28%
Iofina	11.84%	14.89%	5.18%

In the previous week, Iofina had 1 more articles in the media than Synthomer. MarketBeat recorded 1 mentions for Iofina and 0 mentions for Synthomer. Synthomer's average media sentiment score of 1.50 beat Iofina's score of 0.00 indicating that Synthomer is being referred to more favorably in the media.

Company	Overall Sentiment
Synthomer	Very Positive
Iofina	Neutral

Iofina has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synthomer	£1.74B	0.08	-£82.04M	-£96.00	N/A
Iofina	£66.52M	1.61	£4.28M	£4.00	13.96

15.3% of Synthomer shares are owned by institutional investors. Comparatively, 1.5% of Iofina shares are owned by institutional investors. 5.0% of Synthomer shares are owned by company insiders. Comparatively, 13.4% of Iofina shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Synthomer has a beta of 1.02, suggesting that its stock price is 2% more volatile than the broader market. Comparatively, Iofina has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market.

Synthomer currently has a consensus price target of GBX 86.75, suggesting a potential upside of 0.94%. Iofina has a consensus price target of GBX 60, suggesting a potential upside of 7.45%. Given Iofina's stronger consensus rating and higher probable upside, analysts clearly believe Iofina is more favorable than Synthomer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synthomer	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Iofina beats Synthomer on 12 of the 16 factors compared between the two stocks.

How does Iofina compare to Hardide?

Iofina (LON:IOF) and Hardide (LON:HDD) are both small-cap basic materials companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings.

Iofina has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market. Comparatively, Hardide has a beta of 1.106, meaning that its share price is 11% more volatile than the broader market.

Iofina currently has a consensus price target of GBX 60, suggesting a potential upside of 7.45%. Given Iofina's stronger consensus rating and higher probable upside, equities analysts plainly believe Iofina is more favorable than Hardide.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Hardide	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

1.5% of Iofina shares are held by institutional investors. Comparatively, 10.2% of Hardide shares are held by institutional investors. 13.4% of Iofina shares are held by company insiders. Comparatively, 65.7% of Hardide shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Iofina had 1 more articles in the media than Hardide. MarketBeat recorded 1 mentions for Iofina and 0 mentions for Hardide. Iofina's average media sentiment score of 0.00 equaled Hardide'saverage media sentiment score.

Company	Overall Sentiment
Iofina	Neutral
Hardide	Neutral

Hardide has a net margin of 15.60% compared to Iofina's net margin of 11.84%. Hardide's return on equity of 32.49% beat Iofina's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Iofina	11.84%	14.89%	5.18%
Hardide	15.60%	32.49%	-9.80%

Iofina has higher revenue and earnings than Hardide. Iofina is trading at a lower price-to-earnings ratio than Hardide, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Iofina	£66.52M	1.61	£4.28M	£4.00	13.96
Hardide	£8.02M	7.21	-£1.89M	£1.80	40.78

Summary

Iofina beats Hardide on 8 of the 15 factors compared between the two stocks.

Get Iofina News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IOF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IOF vs. The Competition

Export

Metric	Iofina	Specialty Chemicals Industry	Materials Sector	LON Exchange
Market Cap	£107.13M	£9.00B	£4.54B	£2.78B
Dividend Yield	2.88%	3.35%	5.04%	6.12%
P/E Ratio	13.96	15.96	21.13	368.21
Price / Sales	1.61	116.70	6,320.45	84,742.79
Price / Cash	7.96	19.72	26.46	27.87
Price / Book	2.49	3.42	9.01	7.52
Net Income	£4.28M	£213.62M	£157.11M	£5.89B
7 Day Performance	-0.29%	-0.20%	-0.51%	-0.18%
1 Month Performance	16.33%	-0.29%	-3.85%	-0.92%
1 Year Performance	123.36%	22.67%	38.60%	61.94%

Iofina Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IOF Iofina	1.607 of 5 stars	GBX 55.84 -2.0%	GBX 60 +7.4%	+133.6%	£107.13M	£66.52M	13.96	95
ESNT Essentra	4.0561 of 5 stars	GBX 84.29 +2.7%	GBX 150 +78.0%	-23.3%	£240.37M	£302M	120.42	350	Gap Up
ZTF Zotefoams	N/A	GBX 455 +4.1%	GBX 605 +33.0%	+40.5%	£223.78M	£158.49M	10.14	549	Gap Up
TET Treatt	N/A	GBX 305 flat	GBX 248.33 -18.6%	N/A	£180.06M	£128.29M	42.24	350
SYNT Synthomer	1.8863 of 5 stars	GBX 88 +2.2%	GBX 86.75 -1.4%	-13.6%	£144.27M	£1.74B	N/A	4,200	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:IOF) was last updated on 7/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Iofina (IOF) Competitors